U.S. regulators are trying to shut down the industry for compounded weight-loss drugs, which could result in higher costs or ...

A group of Democratic senators are calling on Health and Human Services Secretary Robert F. Kennedy Jr. to keep a proposed ...

Pfizer is ending the development of its potential once-daily pill treatment for obesity before venturing into the biggest and ...

A new guideline for treating obesity in children and adolescents says medication can be helpful, but that health providers ...

Researchers found that by December 2023, more than 1 in 3 of the medications being started for type 2 diabetes treatment were GLP-1RA-based medications.

A diverse range of medical specialists offer unique expertise for obesity treatment. “Endocrinologists, bariatricians, obesity specialists and psychiatrists can prescribe weight loss medication,” ...

A decision by CMS to not move forward with a proposed rule allowing obesity medications to be covered under Medicare Part D ...

Tirzepatide is approved for 3 indications in the US: type 2 diabetes, chronic weight management, and obstructive sleep apnea.

Pfizer has stopped developing a once-daily pill to treat obesity after a person in a clinical trial showed signs of a ...

When it comes to managing weight loss and type 2 diabetes with medications, research shows that it's out with the old and in ...

People taking GLP-1 drugs can decrease fat mass while minimizing muscle loss with a few key strategies that include proper ...